FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 360:1785-1786 April 23, 2009 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

Because of its very nature, the gastrointestinal tract is potentially subject to inflammation and infection. Much of its surface is designed to be highly exposed and absorptive, yet it faces a tremendous microbial population. Therefore, it is not surprising that various gastrointestinal disorders are linked to microbial infection or toxins. For example, peptic ulcers, affecting approximately 10% of the population in the United States, are caused in part by infection with Helicobacter pylori. Accordingly, treatment for this type of ulcer includes antibiotics.

Unfortunately, less success has been achieved in managing another often debilitating disorder, Crohn's disease, an inflammatory disease . . . [Full Text of this Article]

Source Information

From the Life Sciences Institute, University of Michigan, Ann Arbor.

This article (10.1056/NEJMcibr0810347) was published at NEJM.org on April 15, 2009.

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.